Compassionate Use Programs are designed for patients who have a
serious or urgent, life-threatening disease whose treatment has
been unsuccessful with available medicinal products licensed by the
Turkish Medicines and Medical Devices Agency (“Agency”)
in Turkey and who cannot be included in the clinical trials on this
subject. The Compassionate Use Program aims to provide the drug,
which is not licensed in Turkey, but licensed or not in other
countries, by the company that develops / supplies the drug for
humanitarian reasons.
Regarding the scope and execution of the Compassionate Use
Program, Guidelines on Compassionate Use ("Guidelines")
and the annexes of the Guidelines is published on the website of
the Agency.